N-Acetylcysteine and Acetylsalicylic Acid Inhibit Alcohol Consumption by Different Mechanisms: Combined Protection
Author
dc.contributor.author
Quintanilla González, María Elena
Author
dc.contributor.author
Ezquer, Fernando
Author
dc.contributor.author
Morales Retamales, Paola
Author
dc.contributor.author
Ezquer, Marcelo
Author
dc.contributor.author
Olivares, Belén
Author
dc.contributor.author
Santapau, Daniela
Author
dc.contributor.author
Herrera-Marschitz Muller, Mario
Author
dc.contributor.author
Israel Jacard, Yedy
Admission date
dc.date.accessioned
2020-11-02T20:07:46Z
Available date
dc.date.available
2020-11-02T20:07:46Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Frontiers in Behavioral Neuroscience July 2020 | Volume 14 | Article 122
es_ES
Identifier
dc.identifier.other
10.3389/fnbeh.2020.00122
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/177500
Abstract
dc.description.abstract
Chronic ethanol intake results in brain oxidative stress and neuroinflammation, which have been postulated to perpetuate alcohol intake and to induce alcohol relapse. The present study assessed the mechanisms involved in the inhibition of: (i) oxidative stress; (ii) neuroinflammation; and (iii) ethanol intake that follow the administration of the antioxidant N-acetylcysteine (NAC) and the anti-inflammatory acetylsalicylic acid (ASA) to animals that had consumed ethanol chronically. At doses used clinically, NAC [40 mg/kg per day orally (p.o.)] and ASA (15 mg/kg per day p.o.) significantly inhibited chronic alcohol intake and relapse intake in alcohol-preferring rats. The coadministration of both drugs reduced ethanol intake by 65% to 70%. N-acetylcysteine administration: (a) induced the Nrf2-ARE system, lowering the hippocampal oxidative stress assessed as the ratio of oxidized glutathione (GSSG)/reduced glutathione (GSH); (b) reduced the neuroinflammation assessed by astrocyte and microglial activation by immunofluorescence; and (c) inhibited chronic and relapse ethanol intake. These effects were blocked by sulfasalazine, an inhibitor of the xCT transporter, which incorporates cystine (precursor of GSH) and extrudes extracellular glutamate, an agonist of the inhibitory mGlu2/3 receptor, which lowers the synaptic glutamatergic tone. The inhibitor of mGlu2/3 receptor (LY341495) blocked the NAC-induced inhibition of both relapse ethanol intake and neuroinflammation without affecting the GSSG/GSH ratio. Unlike N-acetylcysteine, ASA inhibited chronic alcohol intake and relapsevialipoxin A4, a strong anti-inflammatory metabolite of arachidonic acid generated following the ASA acetylation of cyclooxygenases. Accordingly, the lipoxin A4 receptor inhibitor, WRW4, blocked the ASA-induced reduction of ethanol intake. Overall,viadifferent mechanisms, NAC and ASA administered in clinically relevant doses combine their effects inhibiting ethanol intake.
es_ES
Patrocinador
dc.description.sponsorship
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT
1180042
1190562
1200287